ASTELLAS' VYLOY™ (ZOLBETUXIMAB-CLZB) APPROVED BY U.S. FDA FOR TREATMENT OF ADVANCED GASTRIC AND GEJ CANCER

Reuters · 10/18 18:13

Please log in to view news